[HTML][HTML] Drug resistance in cancer therapy: the Pandora's Box of cancer stem cells
H Rezayatmand, M Razmkhah… - Stem cell research & …, 2022 - Springer
Drug resistance is the main culprit of failure in cancer therapy that may lead to cancer
relapse. This resistance mostly originates from rare, but impactful presence of cancer stem …
relapse. This resistance mostly originates from rare, but impactful presence of cancer stem …
[HTML][HTML] Drug resistance in cancer therapy: the Pandora's Box of cancer stem cells
H Rezayatmand, M Razmkhah… - … Cell Research & …, 2022 - stemcellres.biomedcentral.com
Drug resistance is the main culprit of failure in cancer therapy that may lead to cancer
relapse. This resistance mostly originates from rare, but impactful presence of cancer stem …
relapse. This resistance mostly originates from rare, but impactful presence of cancer stem …
[PDF][PDF] Drug resistance in cancer therapy: the Pandora's Box of cancer stem cells
H Rezayatmand, M Razmkhah… - Stem Cell Research & …, 2022 - scienceopen.com
Drug resistance is the main culprit of failure in cancer therapy that may lead to cancer
relapse. This resistance mostly originates from rare, but impactful presence of cancer stem …
relapse. This resistance mostly originates from rare, but impactful presence of cancer stem …
Drug resistance in cancer therapy: the Pandora's Box of cancer stem cells
H Rezayatmand, M Razmkhah… - Stem cell research …, 2022 - pubmed.ncbi.nlm.nih.gov
Drug resistance is the main culprit of failure in cancer therapy that may lead to cancer
relapse. This resistance mostly originates from rare, but impactful presence of cancer stem …
relapse. This resistance mostly originates from rare, but impactful presence of cancer stem …
[引用][C] Drug resistance in cancer therapy: the Pandora's Box of cancer stem cells
H Rezayatmand, M Razmkhah… - Stem Cell Research and …, 2022 - elibrary.ru
Drug resistance in cancer therapy: the Pandora's Box of cancer stem cells
H Rezayatmand, M Razmkhah… - Stem Cell Research …, 2022 - search.proquest.com
Drug resistance is the main culprit of failure in cancer therapy that may lead to cancer
relapse. This resistance mostly originates from rare, but impactful presence of cancer stem …
relapse. This resistance mostly originates from rare, but impactful presence of cancer stem …
Drug resistance in cancer therapy: the Pandora's Box of cancer stem cells.
H Rezayatmand, M Razmkhah… - Stem Cell Research & …, 2022 - europepmc.org
Drug resistance is the main culprit of failure in cancer therapy that may lead to cancer
relapse. This resistance mostly originates from rare, but impactful presence of cancer stem …
relapse. This resistance mostly originates from rare, but impactful presence of cancer stem …
Drug resistance in cancer therapy: the Pandora's Box of cancer stem cells
H Rezayatmand, M Razmkhah, I Razeghian-Jahromi - 2022 - agris.fao.org
Drug resistance is the main culprit of failure in cancer therapy that may lead to cancer
relapse. This resistance mostly originates from rare, but impactful presence of cancer stem …
relapse. This resistance mostly originates from rare, but impactful presence of cancer stem …
[HTML][HTML] Drug resistance in cancer therapy: the Pandora's Box of cancer stem cells
H Rezayatmand, M Razmkhah… - Stem Cell Research & …, 2022 - ncbi.nlm.nih.gov
Drug resistance is the main culprit of failure in cancer therapy that may lead to cancer
relapse. This resistance mostly originates from rare, but impactful presence of cancer stem …
relapse. This resistance mostly originates from rare, but impactful presence of cancer stem …
Drug resistance in cancer therapy: the Pandora's Box of cancer stem cells.
H Rezayatmand, M Razmkhah… - Stem Cell Research …, 2022 - search.ebscohost.com
Drug resistance is the main culprit of failure in cancer therapy that may lead to cancer
relapse. This resistance mostly originates from rare, but impactful presence of cancer stem …
relapse. This resistance mostly originates from rare, but impactful presence of cancer stem …